Page last updated: 2024-08-22

4-chlorophenylalanine methyl ester and Asymmetric Diabetic Proximal Motor Neuropathy

4-chlorophenylalanine methyl ester has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aydın, TH; Can, ÖD; Demir Özkay, Ü; Turan, N1
Ohkubo, Y; Takeshita, N; Yamaguchi, I1

Other Studies

2 other study(ies) available for 4-chlorophenylalanine methyl ester and Asymmetric Diabetic Proximal Motor Neuropathy

ArticleYear
Effect of subacute agomelatine treatment on painful diabetic neuropathy: involvement of catecholaminergic mechanisms.
    Fundamental & clinical pharmacology, 2016, Volume: 30, Issue:6

    Topics: Acetamides; Animals; Blood Glucose; Catecholamines; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Fenclonine; Hyperalgesia; Hyperglycemia; Methyltyrosines; Neuralgia; Phentolamine; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Streptozocin

2016
Tiapride attenuates pain transmission through an indirect activation of central serotonergic mechanism.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 275, Issue:1

    Topics: Animals; Central Nervous System; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dopamine Antagonists; Female; Fenclonine; Indoles; Injections, Spinal; Ketanserin; Male; Mice; Nociceptors; Pain; Pain Measurement; Pindolol; Serotonin; Serotonin Antagonists; Somatostatin; Substance P; Synaptic Transmission; Tiapamil Hydrochloride; Tropisetron

1995